News on Gaucher_Disease from BioPortfolio.com http://www.BioPortfolio.com Consolidated Gaucher_Disease news from BioPortfolio.com Wed, 10 Feb 2010 11:33:43 GMT en GSK: Rare Diseases Now Big Businesshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040738&HITNO=0&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040738&THISHREF=http://c.moreover.com/click/here.pl%3fz2538856151%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040738&HITNO=0&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040738&THISHREF=http://c.moreover.com/click/here.pl%3fz2538856151%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCafepharma: GSK forms new specialized R&D unithttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034807&HITNO=1&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034807&THISHREF=http://c.moreover.com/click/here.pl%3fz2535984020%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034807&HITNO=1&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034807&THISHREF=http://c.moreover.com/click/here.pl%3fz2535984020%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNew Statesman: GSK Launches Special Disease Unithttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028145&HITNO=2&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028145&THISHREF=http://c.moreover.com/click/here.pl%3fz2532597301%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028145&HITNO=2&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028145&THISHREF=http://c.moreover.com/click/here.pl%3fz2532597301%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Technology: PREVIEW-Genzyme competition may get clearer at conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030937&HITNO=3&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030937&THISHREF=http://c.moreover.com/click/here.pl%3fz2533901639%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030937&HITNO=3&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030937&THISHREF=http://c.moreover.com/click/here.pl%3fz2533901639%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters: Genzyme competition may get clearer at conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030924&HITNO=4&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030924&THISHREF=http://c.moreover.com/click/here.pl%3fz2533898973%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030924&HITNO=4&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030924&THISHREF=http://c.moreover.com/click/here.pl%3fz2533898973%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSharenet: PREVIEW-Genzyme competition may get clearer at conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031047&HITNO=5&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031047&THISHREF=http://c.moreover.com/click/here.pl%3fz2533958848%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031047&HITNO=5&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031047&THISHREF=http://c.moreover.com/click/here.pl%3fz2533958848%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: PREVIEW-Genzyme competition may get clearer at conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030970&HITNO=6&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030970&THISHREF=http://c.moreover.com/click/here.pl%3fz2533920152%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030970&HITNO=6&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030970&THISHREF=http://c.moreover.com/click/here.pl%3fz2533920152%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: GlaxoSmithKline, Poniard, Protalix Provide Biotech's Latest Mishapshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028003&HITNO=7&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028003&THISHREF=http://c.moreover.com/click/here.pl%3fz2532522024%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028003&HITNO=7&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028003&THISHREF=http://c.moreover.com/click/here.pl%3fz2532522024%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSeeking Alpha: GSK: Rare Diseases Now Big Businesshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030102&HITNO=8&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030102&THISHREF=http://c.moreover.com/click/here.pl%3fz2533443072%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030102&HITNO=8&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030102&THISHREF=http://c.moreover.com/click/here.pl%3fz2533443072%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWall Street Journal Online: 'Israel Pharmaceuticals & Healthcare Report Q1 2010' now available at Fast Market Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026270&HITNO=9&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026270&THISHREF=http://c.moreover.com/click/here.pl%3fz2530553884%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026270&HITNO=9&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026270&THISHREF=http://c.moreover.com/click/here.pl%3fz2530553884%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: GSK launches new specialist unit to research and develop medicines for rare diseaseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026828&HITNO=10&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026828&THISHREF=http://c.moreover.com/click/here.pl%3fz2531374835%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026828&HITNO=10&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026828&THISHREF=http://c.moreover.com/click/here.pl%3fz2531374835%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: GSK Launches New Specialist Unit To Research And Develop Medicines For Rare Diseaseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026625&HITNO=11&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026625&THISHREF=http://c.moreover.com/click/here.pl%3fz2531053210%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026625&HITNO=11&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026625&THISHREF=http://c.moreover.com/click/here.pl%3fz2531053210%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Shire to Present Important Study Findings for Gaucher Disease Treatment and GLD Development Program at the Lyshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025433&HITNO=12&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025433&THISHREF=http://c.moreover.com/click/here.pl%3fz2529766966%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025433&HITNO=12&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025433&THISHREF=http://c.moreover.com/click/here.pl%3fz2529766966%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Protalix Announces Presentation of Phase III Taliglucerase Alfa Data at WORLD Lysosomal Disease Networkhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025436&HITNO=13&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025436&THISHREF=http://c.moreover.com/click/here.pl%3fz2529767524%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025436&HITNO=13&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025436&THISHREF=http://c.moreover.com/click/here.pl%3fz2529767524%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Protalix Announces Presentation of Phase III Taliglucerase Alfa Data at WORLD Lysosomal Disease Networkhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018042&HITNO=14&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018042&THISHREF=http://c.moreover.com/click/here.pl%3fz2525446533%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018042&HITNO=14&MSIZE=294&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Gaucher_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018042&THISHREF=http://c.moreover.com/click/here.pl%3fz2525446533%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: